Sitemap
April 28, 2022 Articles
Filter by Available Specialty
- Adults with asthma at higher risk for obesity
- Asundexian confers lower bleeding rates vs. apixaban for stroke prevention in AF
- Bausch + Lomb announces IPO
- BLOG: Use total corneal, OCT lens measurements to elevate refractive cataract surgery
- Dapagliflozin was well tolerated among patients hospitalized with COVID-19
- Embolization device gains FDA 510(k) clearance
- Exploring the PAVING Program for Breast Cancer Survivors
- Factors predict survival after immunotherapy combination for HNSCC
- Family: The most important thing in life
- Fast track granted for Timber’s congenital ichthyosis candidate
- FDA approves drug for adults with generalized myasthenia gravis
- FDA approves first medication for chronic yeast infection
- FDA grants orphan drug designation to off-the-shelf CAR-T for advanced multiple myeloma
- FDA proposes rules prohibiting menthol cigarettes, flavored cigars
- Fewer menopause symptoms, HT prescriptions among Black and Hispanic vs. white veterans
- Financial strain may explain attrition for some patients in clinical trials
- Incidental respiratory findings on low-dose CT lung cancer screening common
- Industry offers good opportunities for ophthalmologists who want a career change
- Influenza vaccine uptake ‘suboptimal’ in adults with early rheumatoid arthritis
- Internalized skin bias reduces quality of life in patients with hidradenitis suppurativa
- Interventions reduce opioid prescribing after neck dissection for thyroid cancer
- JAK inhibitors have significant impact in psoriatic arthritis, but safety concerns remain
- Long-term IOP, disc hemorrhage risk factors for visual field progression
- Lung ultrasound a promising tool to monitor COVID-19 lung changes after discharge
- Mental health sharply declined in UK young adults during COVID-19 pandemic
- Moderna asks FDA to authorize COVID-19 vaccine in young children
- Moms who receive investigational RSV vaccine pass antibodies to infants
- Most top orthopedic hospitals provide accessible but cryptic cost information for TJA
- Neoadjuvant pembrolizumab does not increase surgical complications in oral cavity cancer
- New investment provides ‘second bite’ transaction to physician practices
- One-quarter of rheumatology trainees felt unsafe in workplace during COVID-19
- Patients with idiopathic angioedema show improvement with omalizumab
- Positive safety results reported for Nyxol in pediatric patients
- Practical tips for deprescribing in older adults
- Q&A: Mediterranean diet for NAFLD goes beyond just following a food list
- Should insurance companies cover medical marijuana for cancer pain?
- Speaker offers tips for obtaining academic position
- SURMOUNT-1: Adults achieve weight loss of 16% or more at 72 weeks with tirzepatide
- Top in hem/onc: Vitamin D deficiency and breast cancer risk; the perpetual ‘yes’
- Type 2 diabetes increases risk for tooth loss
- U.S. Multi-Society Task Force on CRC updates diagnosis, management of rare GI syndromes
- Video: DIAMOND study probes patiromer’s use in reducing hyperkalemia
- VIDEO: Managing obesity with nutrition, pharmacotherapy and bariatric surgery
- Video: New guidelines to usher in ‘new era’ in heart failure
- Virtual, hybrid cardiac rehabilitation programs yield benefits similar to in-person
- With many cannabis products but limited research, ‘education warranted’ for entire oncology workforce
- Xeltis announces positive preliminary results of restorative hemodialysis access graft